At the time of writing, Niagen Bioscience Inc [NAGE] stock is trading at $9.86, down -2.76%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The NAGE shares have gain 2.60% over the last week, with a monthly amount glided 2.39%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Niagen Bioscience Inc [NASDAQ: NAGE] stock has seen the most recent analyst activity on May 27, 2025, when Canaccord Genuity initiated its Buy rating and assigned the stock a price target of $13. Previously, Oppenheimer downgraded its rating to Perform on August 16, 2022. On August 11, 2022, downgrade downgraded it’s rating to Neutral and revised its price target to $2.40 on the stock. ROTH Capital started tracking the stock assigning a Buy rating and suggested a price target of $7 on March 08, 2022. Oppenheimer initiated its recommendation with a Outperform and recommended $6 as its price target on October 16, 2019. B. Riley FBR started tracking with a Buy rating for this stock on February 14, 2019, and assigned it a price target of $7.
For the past year, the stock price of Niagen Bioscience Inc fluctuated between $3.18 and $14.69. Niagen Bioscience Inc [NASDAQ: NAGE] shares were valued at $9.86 at the most recent close of the market.
Analyzing the NAGE fundamentals
According to Niagen Bioscience Inc [NASDAQ:NAGE], the company’s sales were 116.30M for trailing twelve months, which represents an 36.84% jump. Gross Profit Margin for this corporation currently stands at 0.64% with Operating Profit Margin at 0.14%, Pretax Profit Margin comes in at 0.16%, and Net Profit Margin reading is 0.15%. To continue investigating profitability, this company’s Return on Assets is posted at 0.19, Equity is 0.35 and Total Capital is 0.24. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.05.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Niagen Bioscience Inc [NASDAQ:NAGE] has a current ratio of 3.88. As well, the Quick Ratio is 3.24, while the Cash Ratio is 2.7. Considering the valuation of this stock, the price to sales ratio is 6.76, the price to book ratio is 12.22 and price to earnings (TTM) ratio is 45.92.
Transactions by insiders
Recent insider trading involved Lopez Carlos Luis, SVP, General Counsel, that happened on Mar 07 ’25 when 273.0 shares were purchased. Director, Jaksch Frank L Jr completed a deal on Dec 13 ’24 to sell 37161.0 shares. Meanwhile, affiliate Frank Jaksch Jr. bought 37161.0 shares on Dec 13 ’24.
